BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jeon YW, Park IJ, Kim JE, Park JH, Lim SB, Kim CW, Yoon YS, Lee JL, Yu CS, Kim JC. Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy. World J Gastrointest Surg 2021; 13(9): 1000-1011 [PMID: 34621476 DOI: 10.4240/wjgs.v13.i9.1000]
URL: https://www.wjgnet.com/1948-9366/full/v13/i9/1000.htm
Number Citing Articles
1
Angela Damato, Michele Ghidini, Lorenzo Dottorini, Gianluca Tomasello, Alessandro Iaculli, Antonio Ghidini, Andrea Luciani, Fausto Petrelli. Chemotherapy Duration for Various Indications in Colorectal Cancer: a ReviewCurrent Oncology Reports 2023; 25(4): 341 doi: 10.1007/s11912-023-01378-5
2
Neal Bhutiani, Oliver Peacock, George J. Chang. A practical framework for the targeted use of total neoadjuvant therapy for rectal cancerCancer 2022; 128(11): 2064 doi: 10.1002/cncr.34149